• Home
  • Search Results
  • ERK-dependent downregulation of the atypical chemokine receptor D6 drives tumor aggressiveness in Kaposi sarcoma.

ERK-dependent downregulation of the atypical chemokine receptor D6 drives tumor aggressiveness in Kaposi sarcoma.

Cancer immunology research (2014-05-23)
Benedetta Savino, Nicoletta Caronni, Achille Anselmo, Fabio Pasqualini, Elena Monica Borroni, Gianluca Basso, Giuseppe Celesti, Luigi Laghi, Athanasia Tourlaki, Vinicio Boneschi, Lucia Brambilla, Manuela Nebuloni, Gianluca Vago, Alberto Mantovani, Massimo Locati, Raffaella Bonecchi
ABSTRACT

D6 is an atypical chemokine receptor acting as a decoy and scavenger for inflammatory CC chemokines expressed in lymphatic endothelial cells. Here, we report that D6 is expressed in Kaposi sarcoma (KS), a tumor ontogenetically related to the lymphatic endothelium. Both in human tumors and in an experimental model, D6 expression levels were inversely correlated with tumor aggressiveness and increased infiltration of proangiogenic macrophages. Inhibition of monocyte recruitment reduced the growth of tumors, while adoptive transfer of wild-type, but not CCR2(-/-) macrophages, increased the growth rate of D6-competent neoplasms. In the KS model with the B-Raf V600E-activating mutation, inhibition of B-Raf or the downstream ERK pathway induced D6 expression; in progressing human KS tumors, the activation of ERK correlates with reduced levels of D6 expression. These results indicate that activation of the K-Ras-B-Raf-ERK pathway during KS progression downregulates D6 expression, which unleashes chemokine-mediated macrophage recruitment and their acquisition of an M2-like phenotype supporting angiogenesis and tumor growth. Combined targeting of CCR2 and the ERK pathway should be considered as a therapeutic option for patients with KS.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Indomethacin, 98.5-100.5% (in accordance with EP)
Sigma-Aldrich
Diethyl azodicarboxylate solution, 40 wt. % in toluene
Supelco
Indomethacin, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Human VEGF-A ELISA Kit, for serum, plasma, cell culture supernatants and urine
Sigma-Aldrich
Indomethacin, meets USP testing specifications
USP
Indomethacin, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Human VEGF ELISA Kit, for cell and tissue lysates
Indomethacin, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Mouse VEGF ELISA Kit, for serum, plasma, cell culture supernatant
Sigma-Aldrich
Rat VEGF ELISA Kit, for serum, plasma and cell culture supernatant
Sigma-Aldrich
Mouse VEGF ELISA Kit, for cell and tissue lysates
Sigma-Aldrich
Rat VEGF ELISA Kit, for cell and tissue lysates
Sigma-Aldrich
Human VEGF R3 ELISA Kit, for serum, plasma, cell culture supernatant, urine
Sigma-Aldrich
Human VEGF R2 ELISA Kit, for serum, plasma, cell culture supernatant and urine